DRFE:CA:TSX-Desjardins RI Emerging Markets Multifactor - Low CO2 (CAD)

COMMON STOCK | |

Last Closing

CAD 22.4

Change

-0.05 (-0.22)%

Market Cap

CAD 0.13B

Volume

1.30K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-24 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap
TD-PFD:CA Toronto Dominion Bank Pref D

+0.05 (+0.21%)

CAD 169.00B
TD-PFI:CA Toronto-Dominion Bank Pref Ser..

+0.05 (+0.19%)

CAD 163.35B
ENB-PFV:CA Enbridge Inc Pref 5

N/A

CAD 118.62B
ENB-PFA:CA Enbridge Inc Pref 9

+0.03 (+0.16%)

CAD 113.39B
ENB-PFC:CA Enbridge Inc Pref 11

+0.01 (+0.06%)

CAD 109.24B
ENB-PFG:CA Enbridge Inc Pref 15

N/A

CAD 105.77B
ENB-PFU:CA Enbridge Inc Pref L

+0.03 (+0.13%)

CAD 87.46B
PPL-PFA:CA Pembina Pipeline Corp Pref Ser..

+0.04 (+0.17%)

CAD 9.59B
EIT-UN:CA Canoe EIT Income Fund

+0.06 (+0.42%)

CAD 2.55B
EVT:CA Economic Investment Trust Ltd

N/A

CAD 0.89B

ETFs Containing DRFE:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification () Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.11% N/A N/A 74% C
Dividend Return 0.88% N/A N/A 28% F
Total Return 12.99% N/A N/A 74% C
Trailing 12 Months  
Capital Gain 18.52% N/A N/A 73% C
Dividend Return 0.93% N/A N/A 17% F
Total Return 19.45% N/A N/A 71% C-
Trailing 5 Years  
Capital Gain 16.91% N/A N/A 52% F
Dividend Return 5.60% N/A N/A 24% F
Total Return 22.51% N/A N/A 49% F
Average Annual (5 Year Horizon)  
Capital Gain 3.76% N/A N/A 56% F
Dividend Return 4.71% N/A N/A 54% F
Total Return 0.95% N/A N/A 33% F
Risk Return Profile  
Volatility (Standard Deviation) 13.40% N/A N/A 59% D-
Risk Adjusted Return 35.15% N/A N/A 58% F
Market Capitalization 0.13B N/A N/A 42% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike